Vanda Pharmaceuticals (VNDA) Inventory Average (2012 - 2026)

Vanda Pharmaceuticals (VNDA) has 15 years of Inventory Average data on file, last reported at $6.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 11.22% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 11.22% YoY), and the FY2025 full-year result was $10.3 million, up 88.9% from the prior year.
• Inventory Average fell to $6.4 million in Q1 2026, from $10.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $11.3 million in Q4 2022 to a low of $1.4 million in Q2 2022.
• A 5-year average of $6.5 million and a median of $6.1 million in 2025 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average soared 649.07% in 2023 and sank 87.1% in 2024, its largest moves.
• Tracing VNDA's Inventory Average over 5 years: stood at $11.3 million in 2022, then tumbled by 48.55% to $5.8 million in 2023, then surged by 64.23% to $9.5 million in 2024, then climbed by 10.54% to $10.5 million in 2025, then tumbled by 39.6% to $6.4 million in 2026.
• Business Quant data shows VNDA's Inventory Average at $6.4 million in Q1 2026, $10.5 million in Q4 2025, and $6.1 million in Q3 2025.